Xiaokai Ding

482 total citations
21 papers, 211 citations indexed

About

Xiaokai Ding is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiaokai Ding has authored 21 papers receiving a total of 211 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Molecular Biology. Recurrent topics in Xiaokai Ding's work include Renal Diseases and Glomerulopathies (9 papers), Systemic Lupus Erythematosus Research (5 papers) and Vasculitis and related conditions (4 papers). Xiaokai Ding is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Systemic Lupus Erythematosus Research (5 papers) and Vasculitis and related conditions (4 papers). Xiaokai Ding collaborates with scholars based in China, United States and Russia. Xiaokai Ding's co-authors include Chaosheng Chen, Jianna Zhang, Ying Zhou, Bo Chen, Ji Zhang, Xinxin Chen, Ting Chen, Chenfei Zheng, Fan Lin and Duo Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer Research and Human Pathology.

In The Last Decade

Xiaokai Ding

20 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaokai Ding China 9 106 55 46 40 34 21 211
Harikleia Gakiopoulou Greece 9 49 0.5× 101 1.8× 19 0.4× 17 0.4× 21 0.6× 33 231
Zhangsuo Liu China 4 72 0.7× 52 0.9× 84 1.8× 23 0.6× 8 0.2× 7 195
Saba Kiremitçi Türkiye 10 60 0.6× 76 1.4× 28 0.6× 15 0.4× 18 0.5× 42 266
Rima S. Zahr United States 6 52 0.5× 38 0.7× 24 0.5× 41 1.0× 6 0.2× 19 175
Kenichiro Kojima Japan 9 139 1.3× 50 0.9× 11 0.2× 8 0.2× 20 0.6× 22 217
Carolina Conte Italy 7 103 1.0× 114 2.1× 8 0.2× 16 0.4× 16 0.5× 10 258
E. Endreffy Hungary 7 19 0.2× 95 1.7× 44 1.0× 80 2.0× 11 0.3× 13 253
Amy Fearn United Kingdom 6 128 1.2× 59 1.1× 5 0.1× 14 0.3× 20 0.6× 6 229
Peiran Yin China 8 169 1.6× 38 0.7× 37 0.8× 4 0.1× 40 1.2× 13 223

Countries citing papers authored by Xiaokai Ding

Since Specialization
Citations

This map shows the geographic impact of Xiaokai Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaokai Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaokai Ding more than expected).

Fields of papers citing papers by Xiaokai Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaokai Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaokai Ding. The network helps show where Xiaokai Ding may publish in the future.

Co-authorship network of co-authors of Xiaokai Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaokai Ding. A scholar is included among the top collaborators of Xiaokai Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaokai Ding. Xiaokai Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xinyu, Changsheng Zhang, Jiang Li, & Xiaokai Ding. (2025). Quantitative evaluation of China's adolescent physical activity policies: a PMC Index model approach. Frontiers in Public Health. 13. 1625225–1625225. 1 indexed citations
2.
Ding, Xiaokai, Jiaxin Liang, Amanda C. Sharko, et al.. (2024). Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors. Proceedings of the National Academy of Sciences. 121(47). e2414501121–e2414501121.
3.
Zhang, Ji, et al.. (2023). Clinical Significance of Persistent Hematuria Degrees in Primary IgA Nephropathy: A Propensity Score-Matched Analysis of a 10-Year Follow-Up Cohort. American Journal of Nephrology. 54(1-2). 62–73. 5 indexed citations
4.
Zhang, Ji, Bo Chen, Yan Liang, et al.. (2023). Efficacy and safety of belimumab in patients with lupus nephritis: a real-world retrospective observational study. Lara D. Veeken. 64(2). 614–622. 8 indexed citations
5.
Ding, Xiaokai, Amanda C. Sharko, Martina S.J. McDermott, et al.. (2022). Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo. Proceedings of the National Academy of Sciences. 119(32). e2201073119–e2201073119. 20 indexed citations
6.
Sharko, Amanda C., Xiaokai Ding, Chang‐Uk Lim, et al.. (2022). Abstract P4-01-17: Preventing adaptive therapeutic resistance to CDK4/6 inhibition with CDK8/19 inhibitors. Cancer Research. 82(4_Supplement). P4–1. 1 indexed citations
7.
Zhang, Ji, et al.. (2021). Role of clinicopathological features for the early prediction of prognosis in lupus nephritis. Immunologic Research. 69(3). 285–294. 3 indexed citations
8.
Chen, Qing, et al.. (2021). Clinicopathological and prognostic study of IgA-dominant postinfectious glomerulonephritis. BMC Nephrology. 22(1). 248–248. 5 indexed citations
9.
Lai, Jin Shei, Shujuan Zhou, Siqi Wu, et al.. (2021). A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China. Medical Science Monitor. 27. e930097–e930097. 20 indexed citations
10.
Zhou, Shujuan, Xiaokai Ding, Siqi Wu, et al.. (2021). A Web of Science-based scientometric analysis about mammalian target of rapamycin signaling pathway in kidney disease from 1986 to 2020. Translational Andrology and Urology. 10(3). 1006–1017. 7 indexed citations
11.
Ding, Xiaokai, et al.. (2020). Antiphospholipid antibodies in patients with proliferative and membranous lupus nephritis. Clinical Rheumatology. 39(5). 1531–1535. 6 indexed citations
12.
Zhang, Jianna, et al.. (2020). Predictors of renal outcomes in crescentic and mixed class of ANCA-associated glomerulonephritis. Clinical Nephrology. 95(2). 81–86. 7 indexed citations
13.
Guo, Gangqiang, Lele Ye, Huijing Wang, et al.. (2020). TCONS_00483150 as a Novel Diagnostic Biomarker of Systemic Iupus Erythematosus. Epigenomics. 12(11). 973–988. 10 indexed citations
14.
Zheng, Chenfei, Ji Zhang, Xinxin Chen, et al.. (2019). MicroRNA-155 Mediates Obesity-Induced Renal Inflammation and Dysfunction. Inflammation. 42(3). 994–1003. 23 indexed citations
15.
Su, Xiaoping, Lele Ye, Xinxin Chen, et al.. (2019). MiR-199-3p promotes ERK-mediated IL-10 production by targeting poly (ADP-ribose) Polymerase-1 in patients with systemic lupus erythematosus. Chemico-Biological Interactions. 306. 110–116. 15 indexed citations
16.
Chen, Xinxin, Yu Chen, Xiaokai Ding, et al.. (2019). Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy. Renal Failure. 41(1). 363–369. 15 indexed citations
17.
Pan, Min, Ji Zhang, Duo Li, et al.. (2018). Renal outcomes in primary IgA nephropathy patients with segmental glomerular necrosis: a case–control study. Human Pathology. 75. 47–54. 3 indexed citations
18.
19.
Zhang, Xiangyang, et al.. (2017). Protective effect of regular physical activity on major depressive episodes in patients with early stages of chronic kidney disease. Renal Failure. 39(1). 602–606. 5 indexed citations
20.
Chen, Ting, Xiaokai Ding, & Bo Chen. (2009). Value of the RIFLE classification for acute kidney injury in diffuse proliferative lupus nephritis. Nephrology Dialysis Transplantation. 24(10). 3115–3120. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Harikleia Gakiopoulou Breakdown of academic impact, for papers by Zhangsuo Liu Breakdown of academic impact, for papers by Saba Kiremitçi Breakdown of academic impact, for papers by Rima S. Zahr Breakdown of academic impact, for papers by Kenichiro Kojima Breakdown of academic impact, for papers by Carolina Conte Breakdown of academic impact, for papers by E. Endreffy Breakdown of academic impact, for papers by Amy Fearn Breakdown of academic impact, for papers by Peiran Yin
Rankless by CCL
2026